TOG Review (RCOG Journal)

MRCOG Part 2

Postpartum Problems (Maternal)

The use of psychotropic medication in the perinatal period

Key Statistics

  • 10–20% — Women with a perinatal mental health problem
  • 47% — Clinicians advising stopping antidepressants once pregnant
  • 10% / 30–40% — Valproate: Major malformation / neurodevelopmental disorder risk

Don't-miss facts

  1. Sodium valproate is contraindicated in anyone of childbearing potential (10% malformation, 30–40% neurodevelopmental disorder risk) except under the Pregnancy Prevention Programme

  2. Lithium: level 12h post-dose; toxic >1.2 mmol/L, potentially fatal >2.0 mmol/L; breastfeeding not currently recommended; never use cabergoline to suppress lactation

  3. Clozapine – breastfeeding contraindicated; monitor in-utero exposed infants for agranulocytosis for 6 months

  4. PNAS (up to 30% antidepressant-exposed) is not dose-dependent – do NOT reduce dose near term to try to prevent it

  5. Olanzapine/quetiapine specifically raise GDM and macrosomia risk – offer 28-week OGTT

  6. Carbamazepine/enzyme inducers reduce hormonal contraceptive efficacy – offer alternative postnatal contraception; give newborn IM vitamin K

  7. Benzodiazepine severe CNS depression is reversible with flumazenil; discourage co-sleeping on sedating medication (SIDS risk)

  8. 47% of clinicians still advise stopping antidepressants on confirmation of pregnancy – guidelines advise against routine discontinuation

Safety snapshot

Generally compatible: SSRIs (sertraline pref. in breastfeeding), SNRIs, NaSSAs, TCAs, FGAs/SGAs (not clozapine), benzodiazepines (lorazepam pref.), Z-hypnotics, antihistamines

Contraindicated/high caution: sodium valproate (childbearing potential); lithium + breastfeeding; clozapine + breastfeeding; cabergoline for lactation suppression in lithium/psychosis risk

Abbreviation Key

  • SSRI — selective serotonin reuptake inhibitor
  • GDM — gestational diabetes mellitus
  • SNRI — serotonin and noradrenaline reuptake inhibitor
  • OGTT — oral glucose tolerance test
  • NaSSA — noradrenaline and specific serotonergic antidepressant
  • HBGM — home blood glucose monitoring
  • TCA — tricyclic antidepressant
  • FASP — fetal anomaly screening programme
  • FGA/SGA — first-/second-generation antipsychotic; SGA also =
  • LBW — low birth weight small for gestational age (context dependent)
  • FBC — full blood count
  • PNAS — poor neonatal adaptation syndrome
  • CS — caesarean section
  • PPHN — persistent pulmonary hypertension of the newborn
  • UKTIS — UK Teratology Information Service
  • EPSE — extrapyramidal side effect
  • BUMPS — Best Use of Medicines in Pregnancy
  • NMS — neuroleptic malignant syndrome
  • LactMed — Drugs and Lactation Database

Source: Petrosellini C et al. The use of psychotropic medication in the perinatal period. The Obstetrician & Gynaecologist 2024;26:127–138. doi:10.1111/tog.12936

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free